仁恒医药 (870511.OC)

+ 收藏

财务摘要(报告期)(仁恒医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) 0.250.29-0.34-0.230.03
 每股收益 - 稀释(元) 0.250.29-0.34-0.230.03
 每股收益 - 期末股本摊薄(元) 0.250.29-0.34-0.230.03
 每股净资产BPS(元) 2.712.451.832.142.43
 每股经营活动产生的现金流量净额(元) -1.20-0.29-0.60-0.32-0.42
 每股营业收入(元) 2.194.151.512.441.52
关键比率:
 净资产收益率 - 摊薄(%) 9.3111.78-18.38-10.631.38
 净资产收益率 - 加权(%) 9.7612.52-16.83-10.411.48
 净资产收益率 - 平均(%) 9.7612.52-16.83-12.311.68
 净资产收益率 - 扣除(%) 8.728.96-20.60-12.500.52
 总资产净利率 - 平均(%) 4.035.40-7.99-6.380.96
 总资产报酬率ROA(%) 4.316.35-7.47-7.151.33
 投入资本回报率ROIC(%) 6.218.58-9.84-7.871.81
 销售毛利率(%) 66.7148.7438.4940.7739.10
 销售净利率(%) 11.026.03-22.32-10.462.36
 资产负债率(%) 60.6754.8859.5646.0528.58
 资产周转率(倍) 0.370.900.360.610.41
 销售商品提供劳务收到的现金/营业收入(%) 81.3996.87105.03103.7177.00
 营业利润同比增长率(%) 166.50175.42-1,063.27-37.23115.90
 营业收入同比增长率(%) 45.3269.61-0.8048.47313.57
 利润总额同比增长率(%) 166.49175.09-1,038.06-37.24116.38
 归属母公司股东的净利润同比增长率(%) 174.94225.59-1,100.61-29.61115.37
 扣非后归属母公司股东的净利润同比增长率(%) 162.67181.32-3,104.64-24.13105.15
 总资产同比增长率(%) 50.0433.5630.95-2.389.59
 总负债同比增长率(%) 52.8259.19172.92-26.61-38.07
 净资产同比增长率(%) 47.9613.35-24.7037.4558.32
利润表摘要:
 营业总收入(元) 29,482,761.5455,876,178.4420,287,680.1832,943,740.2420,450,622.51
 营业总成本(元) 26,185,446.0852,600,476.0425,264,235.6137,555,456.7220,300,538.87
 营业收入(元) 29,482,761.5455,876,178.4420,287,680.1832,943,740.2420,450,622.51
 营业利润(元) 3,011,336.083,325,055.02-4,528,252.21-4,408,975.68470,093.59
 利润总额(元) 3,011,336.083,324,679.48-4,528,730.37-4,427,871.21482,775.18
 净利润(元) 3,250,473.243,368,078.33-4,528,730.37-3,445,286.02482,775.18
 归属母公司股东的净利润(元) 3,393,938.813,894,780.00-4,528,730.37-3,101,268.29452,598.06
 非经常性损益(元) 213,267.78930,478.70546,631.66544,158.65283,680.31
 归属母公司股东的净利润扣除非经常性损益(元) 3,180,671.032,964,301.30-5,075,362.03-3,645,426.94168,917.75
资产负债表摘要:
 流动资产(元) 59,548,259.8242,308,813.8247,557,820.9139,643,818.4036,793,535.06
 固定资产(元) 7,947,363.079,217,985.037,954,860.117,129,339.907,018,385.74
 长期股权投资(元) 770,504.42780,692.02799,966.93799,966.93-
 资产总计(元) 90,025,466.5571,274,335.9260,001,058.7853,363,400.7845,819,585.34
 流动负债(元) 48,920,823.7533,645,133.3030,137,796.5618,971,408.1913,094,400.27
 非流动负债(元) 5,694,098.645,469,131.705,600,000.005,600,000.00-
 负债合计(元) 54,614,922.3939,114,265.0035,737,796.5624,571,408.1913,094,400.27
 股东权益(元) 35,410,544.1632,160,070.9224,263,262.2228,791,992.5932,725,185.07
 归属母公司股东的权益(元) 36,460,037.5333,066,098.7224,642,588.3529,171,318.7232,725,185.07
 资本公积(元) 9,502,066.199,502,066.199,502,066.199,502,066.199,502,066.19
 盈余公积(元) 2,062,746.812,062,746.811,169,268.861,169,268.861,169,268.86
 未分配利润(元) 11,416,474.538,022,535.72492,503.305,021,233.678,575,100.02
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 23,997,410.9854,129,084.6121,309,130.6234,165,710.9115,746,431.13
 经营活动产生的现金净流量(元) -16,140,270.89-3,866,539.90-8,088,570.02-4,352,233.36-5,625,476.44
 购建固定无形长期资产支付的现金(元) 1,334,518.253,814,539.081,184,522.004,759,035.862,276,047.00
 投资支付的现金(元) -5,200,000.00-12,800,000.001,800,000.00
 投资活动产生的现金净流量(元) -1,224,518.25-1,255,733.36-1,184,522.00-7,974,087.85-2,261,416.27
 取得借款收到的现金(元) 17,400,000.0024,800,000.0013,800,000.0011,800,000.002,600,000.00
 筹资活动产生的现金净流量(元) 11,782,642.414,195,933.237,863,601.083,813,429.491,442,145.80
 现金及现金等价物净增加(元) -5,582,146.73-926,340.03-1,409,490.94-8,512,891.26-6,444,746.91
 期末现金及现金等价物余额(元) 2,935,722.438,517,869.168,034,718.259,444,209.1911,512,353.54
 折旧与摊销(元) 2,116,650.643,436,258.121,190,392.992,242,279.04897,287.77
公告日期 2024-08-282024-04-292023-08-282023-04-252022-08-26
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院